The NCI Brain Malignancies Steering Committee (BMSC) was established in 2010. It addresses the design, prioritization, and evaluation of concepts for large phase 2 and phase 3 clinical trials in adult brain cancers and all pediatric brain cancer trials. View the BMSC roster as of November 7, 2025. The committee may hold clinical trials planning meetings (CTPMs) to focus on specific clinical trial related topics.
Committee Highlights
The following are highlights from recent committee activities :
- Improving the Treatment of Glioblastoma
The BMSC held a CTPM in September 2013 to translate advances in both immunotherapy and targeted therapies into concepts for clinical trials in glioblastoma. Read the executive summary and the Targeted Therapies Working Group report in Neuro-oncology.
Contact
For more information, contact NCI CCCT Program Director, Abdul Tawab Amiri, Ph.D., at atawab@mail.nih.gov.